Literature DB >> 23244772

Biobehavioral reactivity to social evaluative stress in women with borderline personality disorder.

Lori N Scott1, Kenneth N Levy, Douglas A Granger.   

Abstract

Several clinical theories propose that borderline personality disorder (BPD) is characterized by a biologically based affective vulnerability to intense affective experiences and impaired modulation of affective states, which might manifest in high emotional intensity, hyperreactivity, and impaired recovery to baseline. However, few studies have tested these theories based on emotional and biological responses of BPD participants in response to psychosocial stressors. This study examined cortisol, alpha-amylase, and subjective emotional reactivity to social evaluative stress among women with BPD compared with two healthy female control groups: a trait-matched (TM) group scoring similarly to the BPD group on trait measures of negative affect and impulsivity, and a non-trait-matched (NTM) group. Results generally suggested high emotional intensity and high baseline psychobiological arousal among individuals with BPD, but not emotional hyperreactivity or impaired recovery specific to the stressor. Relative to both control groups, BPD participants had higher baseline and overall subjective negative affect, higher baseline cortisol levels, and attenuated stress-related cortisol reactivity. In addition, both the BPD and TM groups had attenuated alpha-amylase reactivity in comparison to the NTM group. The differences between BPD and TM groups on most of the dependent measures suggest that emotional dysregulation in BPD is not merely an extreme variant of normative personality traits. These results suggest that women with BPD demonstrate intense and chronic negative affectivity along with high resting psychobiological arousal and attenuated psychobiological reactivity specific to laboratory stressors. PsycINFO Database Record (c) 2013 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23244772      PMCID: PMC3635672          DOI: 10.1037/a0030117

Source DB:  PubMed          Journal:  Personal Disord        ISSN: 1949-2723


  33 in total

1.  Increased psychological and attenuated cortisol and alpha-amylase responses to acute psychosocial stress in female patients with borderline personality disorder.

Authors:  Urs M Nater; Martin Bohus; Elvira Abbruzzese; Beate Ditzen; Jens Gaab; Nikolaus Kleindienst; Ulrich Ebner-Priemer; Jana Mauchnik; Ulrike Ehlert
Journal:  Psychoneuroendocrinology       Date:  2010-07-13       Impact factor: 4.905

Review 2.  Defining the mechanisms of borderline personality disorder.

Authors:  John F Clarkin; Michael Posner
Journal:  Psychopathology       Date:  2005-03-26       Impact factor: 1.944

3.  A preliminary study of cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociation.

Authors:  Daphne Simeon; Margaret Knutelska; Lisa Smith; Bryann R Baker; Eric Hollander
Journal:  Psychiatry Res       Date:  2006-12-12       Impact factor: 3.222

4.  Exaggerated affect-modulated startle during unpleasant stimuli in borderline personality disorder.

Authors:  Erin A Hazlett; Lisa J Speiser; Marianne Goodman; Marcela Roy; Michael Carrizal; Jonathan K Wynn; William C Williams; Michelle Romero; Michael J Minzenberg; Larry J Siever; Antonia S New
Journal:  Biol Psychiatry       Date:  2007-01-29       Impact factor: 13.382

5.  Cortisol response to interpersonal stress in young adults with borderline personality disorder: a pilot study.

Authors:  Marc Walter; Jean-François Bureau; Bjarne M Holmes; Eszter A Bertha; Michael Hollander; Joan Wheelis; Nancy Hall Brooks; Karlen Lyons-Ruth
Journal:  Eur Psychiatry       Date:  2008-03-06       Impact factor: 5.361

6.  The role of affective instability and impulsivity in predicting future BPD features.

Authors:  Sarah L Tragesser; Marika Solhan; Rebecca Schwartz-Mette; Timothy J Trull
Journal:  J Pers Disord       Date:  2007-12

7.  Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders.

Authors:  Thomas H McGlashan; Carlos M Grilo; Charles A Sanislow; Elizabeth Ralevski; Leslie C Morey; John G Gunderson; Andrew E Skodol; M Tracie Shea; Mary C Zanarini; Donna Bender; Robert L Stout; Shirley Yen; Maria Pagano
Journal:  Am J Psychiatry       Date:  2005-05       Impact factor: 18.112

8.  Time course of anger and other emotions in women with borderline personality disorder: a preliminary study.

Authors:  Gitta A Jacob; Cindy Guenzler; Sabine Zimmermann; Corinna N Scheel; Nicolas Rüsch; Rainer Leonhart; Josef Nerb; Klaus Lieb
Journal:  J Behav Ther Exp Psychiatry       Date:  2007-11-24

9.  Disentangling emotion processes in borderline personality disorder: physiological and self-reported assessment of biological vulnerability, baseline intensity, and reactivity to emotionally evocative stimuli.

Authors:  Janice R Kuo; Marsha M Linehan
Journal:  J Abnorm Psychol       Date:  2009-08

10.  Prenatal cocaine exposure and infant cortisol reactivity.

Authors:  Rina D Eiden; Yvette Veira; Douglas A Granger
Journal:  Child Dev       Date:  2009 Mar-Apr
View more
  10 in total

1.  Dual-task performance under acute stress in female adolescents with borderline personality disorder.

Authors:  Michael Kaess; Peter Parzer; Julian Koenig; Franz Resch; Romuald Brunner
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-02-06       Impact factor: 4.785

2.  Pupillary and affective responses to maternal feedback and the development of borderline personality disorder symptoms.

Authors:  Lori N Scott; Maureen Zalewski; Joseph E Beeney; Neil P Jones; Stephanie D Stepp
Journal:  Dev Psychopathol       Date:  2016-10-25

3.  Binge drinking in adolescence predicts an atypical cortisol stress response in young adulthood.

Authors:  Melissa J Hagan; Kathryn Modecki; Lucy Moctezuma Tan; Linda Luecken; Sharlene Wolchik; Irwin Sandler
Journal:  Psychoneuroendocrinology       Date:  2018-10-07       Impact factor: 4.905

4.  Altered psychobiological reactivity but no impairment of emotion recognition following stress in adolescents with non-suicidal self-injury.

Authors:  Julian Koenig; Alexander Lischke; Kay Bardtke; Anna-Lena Heinze; Felix Kröller; Rike Pahnke; Michael Kaess
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-10-06       Impact factor: 5.760

5.  A comprehensive examination of delayed emotional recovery in borderline personality disorder.

Authors:  Skye Fitzpatrick; Janice R Kuo
Journal:  J Behav Ther Exp Psychiatry       Date:  2014-11-18

6.  EEG asymmetry in borderline personality disorder and depression following rejection.

Authors:  Joseph E Beeney; Kenneth N Levy; Lisa M Gatzke-Kopp; Michael N Hallquist
Journal:  Personal Disord       Date:  2013-12-23

7.  Attachment-Related Regulatory Processes Moderate the Impact of Adverse Childhood Experiences on Stress Reaction in Borderline Personality Disorder.

Authors:  Johannes C Ehrenthal; Kenneth N Levy; Lori N Scott; Douglas A Granger
Journal:  J Pers Disord       Date:  2018-01

8.  Serotonergic systems in the balance: CRHR1 and CRHR2 differentially control stress-induced serotonin synthesis.

Authors:  Nina C Donner; Philip H Siebler; Danté T Johnson; Marcos D Villarreal; Sofia Mani; Allison J Matti; Christopher A Lowry
Journal:  Psychoneuroendocrinology       Date:  2015-09-30       Impact factor: 4.905

Review 9.  How Do Stress Exposure and Stress Regulation Relate to Borderline Personality Disorder?

Authors:  Nadège Bourvis; Aveline Aouidad; Clémence Cabelguen; David Cohen; Jean Xavier
Journal:  Front Psychol       Date:  2017-11-30

10.  Homocysteine as a potential indicator of endothelial dysfunction and cardiovascular risk in female patients with borderline personality disorder.

Authors:  Katharina Kern; Kathrin Sinningen; Luisa Engemann; Clara Maiß; Beatrice Hanusch; Andreas Mügge; Thomas Lücke; Martin Brüne
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2022-01-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.